Mark D. Perkins

Louisiana State University Health Sciences Center Shreveport

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse”.

SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse

Nature Microbiology(2021)10.1038/s41564-021-00932-w

N/A

0.863DataRank · unranked

315 citations

Mark D. Perkins, Jens H. Kuhn, Mark J. Pallen, Erik Alm, Brett N. Archer +42 more

An early warning system for emerging SARS-CoV-2 variants

Nature Medicine(2022)10.1038/s41591-022-01836-w

N/A

0.680DataRank · unranked

92 citations

Anne von Gottberg, Lipi Thukral, Nathalie Worp, Bas B. Oude Munnink, Surabhi Rathore +56 more

Global disparities in SARS-CoV-2 genomic surveillance

medRxiv(2021)10.1101/2021.08.21.21262393

N/A

0DataRank · unranked

124 citations

Elizaveta Semenova, Gytis Dudas, Gabriel W. Hassler, Chaney C. Kalinich, Moritz U. G. Kraemer +43 more

SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs

medRxiv(2022)10.1101/2022.05.20.22275319

N/A

0DataRank · unranked

9 citations

Amy Toporowski, Jilian A. Sacks, Mark D. Perkins, Sylvie Briand, Maria D. Van Kerkhove +7 more

SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs

Nature Genetics(2023)10.1038/s41588-022-01267-w

N/A

0DataRank · unranked

39 citations

Amy Toporowski, Jilian A. Sacks, Mark D. Perkins, Sylvie Briand, Maria D. Van Kerkhove +7 more